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OBJECTIVE—In recent genome-wide association studies, vari-
ants in CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, CDKN2B,
LOC387761, and FTO were associated with risk for type 2
diabetes in Caucasians. We investigated the association of these
single nucleotide polymorphisms (SNPs) and some additional tag
SNPs with type 2 diabetes and related quantitative traits in Pima
Indians.
RESEARCH DESIGN AND METHODS—Forty-seven SNPs
were genotyped in 3,501 Pima Indians informative for type 2
diabetes and BMI, among whom 370 had measures of quantitative
traits.
RESULTS—FTO provided the strongest evidence for replica-
tion, where SNPs were associated with type 2 diabetes (odds
ratio  1.20 per copy of the risk allele, P  0.03) and BMI (P 
0.002). None of the other previously reported SNPs were associ-
ated with type 2 diabetes; however, associations were found
between CDKAL1 and HHEX variants and acute insulin response
(AIR), where the Caucasian risk alleles for type 2 diabetes were
associated with reduced insulin secretion in normoglycemic
Pima Indians. Multiallelic analyses of carrying risk alleles for
multiple genes showed correlations between number of risk
alleles and type 2 diabetes and impaired insulin secretion in
normoglycemic subjects (P  0.006 and 0.0001 for type 2
diabetes and AIR, respectively), supporting the hypothesis that
many of these genes inﬂuence diabetes risk by affecting insulin
secretion.
CONCLUSIONS—Variation in FTO impacts BMI, but the impli-
cated common variants in the other genes did not confer a
signiﬁcant risk for type 2 diabetes in Pima Indians. However,
conﬁdence intervals for their estimated effects were consistent
with the small effects reported in Caucasians, and the multiallelic
“genetic risk proﬁle” identiﬁed in Caucasians is associated with
diminished early insulin secretion in Pima Indians. Diabetes 58:
478–488, 2009
A
lthough it has been known for decades that
both type 2 diabetes and obesity have a genetic
basis (1), remarkably few susceptibility genes
with robust and reproducible effects have been
identiﬁed for these diseases. The recent introduction of
large-scale, high-density genome-wide association (GWA)
technology has revolutionized this ﬁeld. Within the past
year, six high-density (300 K) GWA studies to identify
genes affecting risk for type 2 diabetes among Caucasians
have been published, and replicated associations were
reported with single nucleotide polymorphisms (SNPs)
in/near the genes transcription factor 7-like 2 (TCF7L2),
CDK5 regulatory subunit associated protein 1-like 1 (CD-
KAL1), zinc transporter, member 8 (SLC30A8), hemato-
poietically expressed homeobox (HHEX), exostosin 2
(EXT2), insulin-like growth factor 2 mRNA binding protein
2( IGF2BP2), cyclin-dependent kinase inhibitor 2B
(CDKN2B), LOC387761 (a hypothetical gene), and fat
mass and obesity associated (FTO) (2–7). In a prior study,
we thoroughly examined the TCF7L2 locus and deter-
mined that it was not a major gene for type 2 diabetes
among Pima Indians who have a high prevalence of this
disease and a high rate of obesity (8). We also recently
reported results from our GWA study to identify genetic
determinants for type 2 diabetes and obesity in Pima
Indians (9), which did not identify SNPs in any of these
genes as being among the strongest associations for type 2
diabetes. However, this prior GWA used the lower-density
100K Affymetrix array, and none of the reproducibly
associated variants identiﬁed in the high-density GWA
scans of Caucasians are well captured by the 100K array.
Therefore, in the current study, we directly examine the
speciﬁc SNPs reported in Caucasian studies and tag SNPs
to examine alternative variation within CDKAL1,
SLC30A8, and IGF2BP2 to evaluate their potential role in
affecting diabetic status, body weight, and quantitative
metabolic risk factors for diabetes in the Pima Indian
population.
RESEARCH DESIGN AND METHODS
All subjects are part of an ongoing longitudinal study of the etiology of type 2
diabetes in the Gila River Indian Community in Central Arizona (10). The
population-based sample included every full-heritage Pima Indian from the
longitudinal study for whom DNA was available, diabetes status was known,
and height and weight were measured (n  3,501). BMI was computed for
those aged 15 years. Among these subjects, 1,561 had type 2 diabetes (37%
men, mean age of onset 37.2  12.1 years, and mean maximum BMI 38.5  8.4
kg/m
2) and 1,940 were nondiabetic at their last exam (46% men, mean study
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2). Diabetes
was diagnosed according to World Health Organization criteria (11) when the
venous plasma glucose concentration was 200 mg/dl 2 h after a 75-g oral
glucose load, the fasting plasma glucose was 126 mg/dl, or the diagnosis was
made by clinical means. The BMI measurement that was used for association
analysis was the maximum BMI measured when a longitudinally studied
subject was nondiabetic. Measurements made at or after the diagnosis of
diabetes were not included in the analysis. Subjects who were diabetic at their
ﬁrst exam were excluded; therefore, the BMI analyses are restricted to 2,458
subjects.
A subset of these full-heritage Pima Indian subjects (n  370) was also
studied as inpatients in our clinical research center when they were nondia-
betic. All of these subjects (aged 18–45 years) were healthy by medical
history, physical examination, and routine laboratory tests and were not
taking medications. Subjects were fed a weight-maintaining diet for 2–3 days
before they were administered an oral glucose tolerance test (OGTT). For the
OGTT, subjects underwent an overnight fast and then ingested 75 g glucose;
blood was drawn before ingesting the glucose and at 30, 60, 120, and 180 min
thereafter for measurement of plasma glucose and insulin levels. On a
different day, subjects received a 25-g intravenous glucose tolerance test
(IVGTT) to measure acute insulin response (AIR). Blood samples were
collected before infusion and at 3, 4, 5, 6, 8, and 10 min after infusion for
determination of plasma glucose and insulin concentrations. AIR was calcu-
lated as one-half the mean increment in plasma insulin concentrations from 3
to 5 min as previously described (12). Analysis of AIR and 30-min insulin levels
during the OGTT was restricted to subjects with normal glucose tolerance
(n  271) because impaired glucose tolerance is associated with secondary
effects on these measures.
Insulin action was assessed at physiological insulin concentrations during
the hyperinsulinemic-euglycemic clamp technique as previously described
(12). Brieﬂy, after an overnight fast, a primed (30 Ci), continuous (0.3Ci/
min) 3-[
3H]glucose infusion was started to determine the rate of post-
absorptive endogenous glucose production (EGP). Two hours after starting
the isotope infusion, a primed, continuous intravenous insulin infusion was
administered for 100 min at a rate of 40 mU/m
2 body surface area per min.
This infusion achieved a steady-state insulin concentration of 144  42 U/l
(mean  SD). Plasma glucose concentrations were maintained at 100 mg/dl
with a variable infusion of 20% dextrose solution. Blood samples for measure-
ment of 3-[
3H]glucose speciﬁc activity were collected at the end of the basal
period and every 10 min during the ﬁnal 40 min of the insulin infusion. The rate
of total insulin-stimulated glucose disposal (M) was calculated for the last 40
min of the insulin infusion, and M was corrected for mean glucose and insulin
concentrations and EGP during the ﬁnal 40 min of the insulin infusion (12). All
measurements derived from the glucose clamp were normalized to estimated
metabolic body size.
Body composition was estimated by underwater weighing until January
1996 and by dual-energy X-ray absorptiometry (DPX-1; Lunar Radiation,
Madison, WI) thereafter. A conversion equation derived from comparative
analyses was used to make estimates of body composition equivalent between
methods (13). Determination of adipose cell size has previously been de-
scribed (14).
All studies were approved by the Tribal Council of the Gila River Indian
Community and the Institutional Review Board of the National Institute of
Diabetes and Digestive and Kidney Diseases.
SNP selection and genotyping. The present study prioritized genotyping of
16 speciﬁc SNPs (Table 1) reported to be associated with type 2 diabetes in
prior genome-wide studies (2–7). Moreover, because associations with SNPs
in CDKAL1, SLC30A8, and IGF2BP2 replicated in multiple studies of Cauca-
sians and mapped within biological candidate genes, additional SNPs in these
three genes were also genotyped in Pima Indians to search for alternative
variation within the same gene. However, because CDKAL1, in particular, is a
large gene spanning 697.1 kb, tag SNPs were selected from the HapMap CHB
population with a minor allele frequency 0.1 and an r
2 value 0.5 rather
than the more customary r
2 value 0.8, allowing for potentially important
variation to be missed. A total of 47 SNPs were genotyped in 3,501 population-
based full-heritage Pima Indians by the method of SNPlex (Applied Biosys-
tems) following the manufacturer’s protocol. All SNPs were in Hardy-
Weinberg equilibrium (P  0.008); however, SNPs rs9300039 and rs17738231
were monomorphic in Pima Indians.
Statistical analysis. Statistical analyses were performed using the software
of the SAS Institute (Cary, NC). The general association of genotypes with
type 2 diabetes was assessed with logistic regression analysis and was
adjusted for covariates (age, sex, and birth year). The model was ﬁt with a
generalized estimating equation to account for correlation among siblings.
Analyses for type 2 diabetes and BMI are given for an “additive” model in
which homozygotes for the major allele (1/1), heterozygotes (1/2), and
homozygotes for the minor allele (2/2) were coded to a numeric variable for
genotype (0, 1, and 2, respectively). A within-family association analysis
among genotypically discordant siblings was also conducted by a modiﬁcation
of the method of Abecasis et al. (15) to control for any population stratiﬁca-
tion. The association of quantitative traits with genotypes was analyzed by
linear regression using the general estimating equation procedure (GEE; SAS
Institute, Cary, NC). Potentially confounding covariates were included in all
models. BMI was adjusted for age, sex, and birth year. Percent body fat was
adjusted for age and sex. Insulin-stimulated glucose disposal was adjusted for
age, sex, and percent body fat. AIR was adjusted for age, sex, percent body fat,
and insulin-stimulated glucose disposal rate. The 30-min plasma insulin
concentration during an OGTT was adjusted for age, sex, percent body fat,
insulin-stimulated glucose disposal rate, and 30-min plasma glucose concen-
trations. All covariates were speciﬁed a priori based on previous studies of the
determinants of these traits. These models were also ﬁt by generalized
estimating equations to account for correlation among siblings. Plasma insulin
concentrations, insulin-stimulated glucose disposal rates, and AIRs were log
transformed before analysis to approximate a normal distribution. Linkage
disequilibrium and haplotype block analysis were estimated by Haploview
(version 3.32). P values 0.05 were considered statistically signiﬁcant.
For the analysis of heterogeneity in the odds ratios (ORs) between
Caucasians and Pima Indians, a summary OR was calculated for Pima Indians
and Europeans as a weighted sum of the logarithms of the ORs for the
individual studies with the inverse of the variance of the estimate of the
logarithm of the OR as the weight (16). Variances for the European studies
were inferred from the conﬁdence intervals for published studies or, if these
were not available, from the genotypic counts for case and control subjects.
The Q statistic was used to test the null hypothesis that the Pima Indian and
European ORs were equal. Power to detect heterogeneity under the assump-
tion that the true OR in Europeans is the summary observed from published
studies and that the true OR in the Pima Indians is 1 was calculated by the
method of Hedges and Pigott (17).
The magnitude of the previously reported SNP associations in Caucasians
has generally been modest (ORs 1.15). To estimate the power to detect an
association for each variant with the effect observed in Europeans, we
conducted simulations for the present set of families given the observed Pima
Indian allele frequencies under the assumption that the OR is constant with
age. By these methods we estimate that the power of the present study to
detect an OR of 1.15 at P  0.05 is 73% for a risk allele with frequency of 0.5
and 37% for a risk allele with frequency of 0.1. To augment the power to
detect an association, we assumed that most of these alleles do very modestly
affect risk in the Pima population, and we therefore conducted a multiallelic
analysis with the number of risk alleles carried by each individual. In these
analyses, a sentinel SNP for each of the most strongly replicated regions in
Europeans was selected [(rs7756992 in CDKAL1, rs13266634 in SLC30A8,
rs1111875 in HHEX, rs4402960 in IGF2BP2, rs10811661 in CDKN2B,
rs8050136 in FTO, and rs7903146 in TCF7L2, which was described in a
previous publication [8]). The number of risk alleles (“risk” as deﬁned in
studies of Europeans) that each individual carried was summed over all of
these sentinel SNPs, and the associations were analyzed in a fashion analo-
gous to the individual SNPs. This procedure effectively gives equal weights to
each of the risk variants.
RESULTS
CDKAL1. Four SNPs in CDKAL1 (rs4712523, rs10946398,
rs7754840, and rs7756992) previously associated with
type 2 diabetes (3–6) and 25 additional tag SNPs within
CDKAL1 were genotyped in the population-based sample
of 3,501 full-heritage Pima Indians. The four previously
reported SNPs fell into one linkage disequilibrium block 1,
where rs7754840 was in complete linkage disequilibrium
(D1, r
2  0.98) with rs10946398 and rs4712523 and in
high linkage disequilibrium (D0.98, r
2  0.68) with
rs7756992 (supplementary Fig. 1, available in an online
appendix at http://dx.doi.org/10.2337/db08-0877). The al-
lele frequencies of these SNPs were similar between Pima
Indians and Caucasians (rs7754840 C allele  0.26 in Pima
Indians and 0.31 in Caucasians; rs7756992 G allele  0.32
in Pima Indians and 0.26 in Caucasians). None of these
previously reported SNPs or any of the additional tag SNPs
were signiﬁcantly associated with type 2 diabetes in Pima
Indians (Table 1). However, the SNPs in complete linkage
disequilibrium with rs7754840 were nominally associated
with BMI, where Pima Indian subjects carrying the risk
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R. RONG AND ASSOCIATES
DIABETES, VOL. 58, FEBRUARY 2009 481allele for type 2 diabetes reported among Caucasians (C
for rs7754840) were less obese (P  0.01, adjusted for age,
sex, and birth year; Table 1). These variants in CDKAL1,i n
contrast to variants in the genes described below, had a
signiﬁcant interaction with BMI for diabetes risk (e.g., P 
0.01 for interaction with rs7756992, where the interaction
is in the direction that heavier Pima Indians were at
greater risk if they carried the Caucasian risk allele for
diabetes). The four previously reported SNPs in CDKAL1
were also modestly associated with impaired insulin se-
cretion in Pima Indians (rs7756992 shown as representa-
tive in Table 2 and Fig. 1). Among Pima Indians with
normal glucose tolerance, homozygotes for the G allele of
rs7756992 (the type 2 diabetes risk allele in Caucasians)
had a lower mean AIR to an IVGTT (dominant P  0.04,
adjusted for age, sex, percent body fat, and glucose
disposal rate; Fig. 1A) and a lower early (30-min) mean
plasma insulin level during an OGTT (dominant P 
0.0004, adjusted for age, sex, percent body fat, glucose
disposal rate, and 30-min glucose levels; Fig. 1D). The
reduced 30-min insulin response resulted an elevated
trend for plasma glucose levels at 60 min (dominant P 
0.09, adjusted for age, sex, and percent body fat; Fig. 1C).
However, insulin action as assessed by insulin-stimulated
glucose uptake during a hyperinsulinemic-euglycemic
clamp did not differ among the genotypic groups (domi-
nant P  0.97, adjusted for age, sex, and percent body fat;
Fig. 1B). Two database tag SNPs (rs9295479 and
rs2328528) in CDKAL1, each from different linkage dis-
equilibrium blocks (supplementary Fig. 1), were also as-
sociated with both AIR and early (30-min) plasma insulin
levels, the most notable being rs9295479 because of its
common frequency (allele frequency  0.50) among Pima
Indians (adjusted dominant P  0.04 for AIR, adjusted
dominant P  0.003 for 30-min insulin levels; data for
rs9295479 shown in Table 2).
SLC30A8. One SNP in SLC30A8 (rs13266634) was asso-
ciated with type 2 diabetes in multiple GWA studies (2–6).
In Pima Indians, rs13266634 was not associated with type
2 diabetes or BMI (Table 1) and was not associated with
insulin or glucose responses to an OGTT, insulin sensitiv-
ity, or insulin secretion among the 370 metabolically
phenotyped nondiabetic Pima Indian subjects (data not
shown; speciﬁc traits analyzed are listed in Table 2). The
frequency of the C allele (the risk allele in the other
studies) was higher among the Pima Indians (0.91) com-
pared with Caucasians (0.61–0.70) and Chinese (0.52–
0.56), but this allele was also very frequent among Africans
(0.96–0.97). Three additional tag SNPs within/near
SLC30A8 (rs7002176, rs1995222, and rs17738231) were
also genotyped in Pima Indians. Neither rs7002176 nor
rs1995222 was associated with type 2 diabetes or BMI
(Table 1), and rs17738231 was monomorphic.
HHEX. A SNP near HHEX (rs1111875) was previously
associated with type 2 diabetes in multiple studies of
Caucasians (2,4–6,18) and Asians (19–22) but not African
Americans (23). Based on these ﬁndings, rs1111875 and
another SNP within this region (rs10509646) were geno-
typed in the Pima Indian subjects. Rs1111875 was not
associated with type 2 diabetes or BMI (Table 1); however,
among Pima Indians who were normal glucose tolerant,
those homozygous for the previously reported risk allele
(C/C) at rs1111875 had a decreased AIR and a reduced
early (30-min) insulin response to an OGTT (adjusted P
dominant  0.02 and 0.01, respectively; Table 2). A nom-
inal association with type 2 diabetes was observed with
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482 DIABETES, VOL. 58, FEBRUARY 2009rs10509646 (OR 1.15 [95% CI 1.02–1.29], P  0.02, adjusted
for age, sex, and birth year; Table 1).
EXT2. Two SNPs in EXT2 (rs3740878 and rs1113132) that
are in complete linkage disequilibrium in Caucasians and
Chinese were associated with type 2 diabetes in a GWA
study of French Caucasians (2) but were not replicated in
other GWA studies of Caucasians (4–6) or Japanese
populations (19,22). These SNPs were also in complete
linkage disequilibrium in Pima Indians (supplementary
Fig. 1) and were not associated with type 2 diabetes
(rs3740878 shown in Table 1). However, among nondia-
betic Pima Indians, these SNPs were associated with
several measures of insulin resistance, including a lower
insulin-stimulated glucose disposal rate in response to a
hyperinsulinemic-euglycemic clamp (P  0.03, adjusted
for age, sex, and percent body fat; Fig. 2A), and elevated
glucose and insulin levels during an OGTT (P  0.04, 0.03,
and 0.008 for 1-h glucose, 1-h insulin, and 2-h insulin levels,
respectively, adjusted for age, sex, and percent body fat;
Fig. 2C and D), despite no difference in percentage of body
fat (P  0.32, adjusted for age and sex; Fig. 2B). Pima
Indians carrying the type 2 diabetes risk allele reported in
the French Caucasians (A allele for rs3740878) were more
insulin resistant. However, this risk allele is much less
common among Pima Indians compared with Caucasians
(frequency of A allele for rs3740878  0.13 and 0.70 in
Pima Indians and Caucasians, respectively).
IGF2BP2. Two SNPs in IGF2BP2 (rs4402960 and
rs1470579) were associated with type 2 diabetes in several
Caucasian GWA studies (4–6), and the association of
rs4402960 with type 2 diabetes was subsequently repli-
cated in a Danish population (18) and in Asians (21,22) but
not in African Americans (23). These two SNPs were in
high linkage disequilibrium in Pima Indians (D0.99,
r
2  0.98), and the risk alleles were less common among
Pima Indians than among Caucasians (frequencies of T
allele of rs4402960 and C allele of rs1470579  0.17 in Pima
Indians and 0.29 and 0.30 in Caucasians). These SNPs and
two additional tag SNPs within IGF2BP2 (rs6777038 and
rs16860234; supplementary Fig. 1) were genotyped in the
Pima Indians, but none was associated with type 2 diabe-
tes or BMI (Table 1) or any of the diabetes-related quan-
titative traits (data not shown).
CDKN2B. One SNP in CDKN2B (rs10811661) was asso-
ciated with type 2 diabetes in several studies of Cauca-
sians (4–6). This association was strongly replicated in a
Danish population (18) and modestly replicated in Asians
(19,21,22) but not replicated in African Americans (23).
The Danish study also reported that nondiabetic carriers
of the type 2 diabetes risk allele (T) had a lower insulin
response and lower insulin levels at 30 and 120 min during
an OGTT (18); however, a second study of subjects of
European ancestry did not ﬁnd an association between
this SNP and insulin secretion or 
-cell glucose sensitivity
(24). In Pima Indians, rs10811661 was not associated with
type 2 diabetes or BMI (Table 1) or any of the diabetes-
related quantitative traits (data not shown; speciﬁc traits
analyzed are listed in Table 2).
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FIG. 1. Association of CDKAL1 SNP rs7756992 with acute and early insulin secretion. Association of rs7756992 with the AIR to a 25-g bolus
IVGTT (A), insulin-stimulated glucose disposal rate during a hyperinsulinemic-euglycemic clamp (B), plasma glucose levels during a 75-g OGTT
(C), and plasma insulin levels in OGTT (D) among 251 normal glucose tolerant full-heritage Pima Indians. Data are given as means  SE. P values
are given for a dominant model (AA  AG vs. GG) under a general analysis. *P value is adjusted for age, sex, percent body fat, and glucose disposal
rate. †P value is adjusted for age, sex, and percent body fat. ‡P value is adjusted for age, sex, percent body fat, glucose disposal rate, and 30-min
glucose levels.
R. RONG AND ASSOCIATES
DIABETES, VOL. 58, FEBRUARY 2009 483LOC387761 and intergenic chromosome 11p. One SNP
in the predicted gene LOC387761 (rs7480010) and a
second SNP in an intergenic region on chromosome 11p at
42 Mb (rs9300039) were highly associated with type 2
diabetes in two GWA studies of Caucasians (2,5). Among
the Pima Indians, there was no evidence of association
between rs7480010 and type 2 diabetes or BMI (Table 1) or
a diabetes-related quantitative trait (data not shown; spe-
ciﬁc traits analyzed are listed in Table 2). SNP rs9300039
was monomorphic for the C allele.
FTO. SNPs within a region of high linkage disequilibrium
in intron 1 of FTO (rs8050136 and rs9939609) were initially
reported to be associated with BMI and obesity in two
studies of Caucasians (25,26). Although these SNPs were
also associated with type 2 diabetes, their association with
type 2 diabetes was due to the higher BMI of the diabetic
subjects (25). The association of the SNPs with BMI has
been widely replicated in additional studies of Caucasians
and non-Caucasian populations (27–31), although there
have been a few reports of a lack of association (32,33).
The association of rs8050136, rs9939609, and rs7193144,
which were in complete linkage disequilibrium among the
Pima Indians (supplementary Fig. 1), with BMI was repli-
cated in Pima Indians (P  0.002 and 0.002 for the general
and within-family analyses, respectively, where P is ad-
justed for age, sex, and birth year; Table 3). Subjects
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FIG. 2. Association of EXT2 SNP rs3740878 with insulin action. Association of rs3740878 with insulin-stimulated glucose disposal rate during a
hyperinsulinemic-euglycemic clamp (A), percent body fat (B), plasma glucose levels during a 75-g OGTT (C), and plasma insulin levels in OGTT
(D) among 357 nondiabetic full-heritage Pima Indians. Data are given as means  SE. The AA genotype was too rare (n  3) for the mean to be
reliable; therefore, data are presented as GG (n  271) vs. GA  AA (n  86). *P value is adjusted for age, sex, and percent body fat. †P value
is adjusted for age and sex. ‡P values are adjusted for age, sex, and percent body fat.
TABLE 3
Association of rs8050136 in FTO with maximum BMI and fat cell size in full-heritage Pima Indians
Mean  SD (top row) and number of subjects
(bottom row)
P value general analysis (top
row) and within-family
analysis (bottom row)
Trait CC CA AA Additive Recessive
BMI (kg/m
2) 36.1  8.2 36.7  8.0 37.7  8.3 0.002 0.005
1975 624 55 0.002 0.001
Fat cell size (ng lipid/cell) 0.76  0.21 0.84  0.20 0.86  0.25 0.09 0.02
142 36 6 0.006 0.002
P values are given for both additive and recessive models (CC vs. CA 	 AA) due to the small number of AA (n  6) with measures of fat
cell size. All P values were calculated after adjusting for age, sex, and birth year. P values for fat cell size were additionally adjusted for
percent body fat. SNP rs8050136 is in linkage disequilibrium with rs9939609 and rs7193144 (not shown).
CAUCASIAN TYPE 2 DIABETES GENES IN PIMA INDIANS
484 DIABETES, VOL. 58, FEBRUARY 2009homozygous for the risk allele (A for rs8050136) had a
mean BMI that was 1.6 kg/m
2 greater than that of individ-
uals homozygous for the nonrisk allele (C). The risk allele
for high BMI is less common among Pima Indians than
Caucasians (frequency of A allele of rs8050136 is 0.15 vs.
0.45, respectively). Among the metabolically phenotyped
nondiabetic Pima Indians who had undergone abdominal
subcutaneous adipose tissue biopsies, subjects carrying
the risk allele for increased BMI (A allele for rs8050136)
also had larger individual fat cells, even after adjustment
for their higher percentage of body fat (P  0.02 and 0.002
for the general and within-family analyses, respectively;
Table 3). SNPs in FTO were also modestly associated with
type 2 diabetes in Pima Indians (Table 1; OR 1.20 [95% CI
1.02–1.41], P  0.03, adjusted for age, sex, and birth year);
however, the association was weakened and no longer met
statistical signiﬁcance after adjusting for BMI (1.16 [0.98–
1.38], P  0.08), suggesting that the type 2 diabetes
association was largely due to the effect on BMI.
Analysis of heterogeneity and multiallelic association.
Associations of many of these SNPs in CDKAL1,
SLC30A8, HHEX, IGF2BP2, CDKN2B, and FTO with type
2 diabetes have been well-replicated in populations of
European origin; however, the magnitude of these associ-
ations has generally been modest (ORs 1.15). To assess
whether the effects seen in the present study of Pima
Indians were consistent with those observed in previous
studies of European ancestry, we conducted a test for
heterogeneity of the ORs (Table 4). Although, with the
exception of rs8050136 in FTO, none of the SNPs were
associated with diabetes at P  0.05 in Pima Indians, the
conﬁdence intervals for the OR in Pima Indians invariably
included the point estimate for Caucasians. Furthermore,
none of the ORs were signiﬁcantly different between Pima
Indians and Caucasians in a formal heterogeneity test. In
contrast, omitted from Table 4 but shown previously (8),
there was signiﬁcant heterogeneity between Pima Indians
and Caucasians in the ORs for diabetes and SNPs in
TCF7L2, which were not associated with this disease in
Pima Indians.
Results of the multiallelic analysis of all SNPs shown
in Table 4 [plus rs7903146 in TCF7L2 (8)] are shown in Fig.
3A. There was a modest but statistically signiﬁcant in-
crease in prevalence of type 2 diabetes among Pima
Indians carrying increasing numbers of risk alleles, where
risk is deﬁned in Caucasian studies (2–7) (OR 1.10 per
copy of a risk allele [95% CI 1.03–1.19], P  0.006). If
rs8050136 in FTO was excluded from the analysis, this
effect was reduced (1.07 [95% CI 1.00–1.16], P  0.06;
supplementary Fig. 2A, available in the online appendix),
and if rs7903146 in TCF7L2, which has been previously
shown to have heterogeneous effects between Pima Indi-
ans and Caucasians, was further excluded, the OR was
1.09 (95% CI 1.01–1.17) (P  0.03; supplementary Fig. 2B).
These results were largely unmodiﬁed by further adjust-
ment for BMI (e.g., 1.13 [1.05–1.22], P  0.001 for multial-
lelic effect including all variants).
Results for the multiallelic analyses for percent body fat,
insulin sensitivity, and AIR among individuals who had
undergone extensive metabolic phenotyping are shown in
Fig. 3B–D. There was a modest inverse relationship with
body fat, such that an increased number of risk alleles was
associated with lower percent body fat, but this was not
statistically signiﬁcant (P  0.07). Similarly, an increased
number of risk alleles had a nonsigniﬁcant trend toward
increased insulin sensitivity as assessed by the hyperinsu-
linemic-euglycemic clamp (P  0.06). In contrast, there
was a marked decrease in the AIR associated with each
copy of a risk allele (P  0.0001). These results were
largely unchanged when the SNPs in FTO and TCF7L2
were excluded (supplementary Fig. 2C and D).
DISCUSSION
The common forms of type 2 diabetes and obesity are
thought to be complex polygenic diseases. However, it
remains unknown how many genes contribute to these
diseases and whether any single susceptibility gene will be
shared among all ethnic groups or whether all will show
some degree of population speciﬁcity. Recent high-density
GWA studies in humans have identiﬁed speciﬁc variants in
several genes that are associated with type 2 diabetes or
obesity in more than one population and some variants
that are highly associated with type 2 diabetes in one
group of subjects but not others. In our study, we sought
to determine whether these variants and/or genes also
contribute to type 2 diabetes or obesity in the Pima Indian
population in Arizona. In addition, because type 2 diabetes
is a complex heterogeneous disease, a single risk factor or
diabetes-related quantitative trait may be inﬂuenced by
fewer physiological pathways and thus be determined by
fewer genetic loci than the development of type 2 diabetes
itself. Therefore, we also sought to determine whether any
of the variants associated with type 2 diabetes in another
population were associated with a diabetes-related quan-
titative trait in Pima Indians. We have presented the P
TABLE 4
Analysis of heterogeneity between Pima Indians and Caucasians in the association of sentinel SNPs in CDKAL1, SLC30A8, HHEX,
IGF2BP2, CDKN2B, and FTO with type 2 diabetes
Pima Indian risk allele Caucasian risk allele Heterogeneity
SNP Gene Power Frequency OR (95% CI) Frequency OR (95% CI) Power P value
rs7756992 CDKAL1 0.59 0.32 1.10 (0.97–1.25) 0.25 1.14 (1.11–1.18) 0.49 0.59
rs13266634 SLC30A8 0.29 0.91 1.04 (0.84–1.29) 0.75 1.14 (1.11–1.18) 0.22 0.41
rs1111875 HHEX 0.58 0.39 1.04 (0.92–1.18) 0.56 1.13 (1.09–1.16) 0.49 0.20
rs4402960 IGF2BP2 0.43 0.17 1.08 (0.93–1.26) 0.29 1.13 (1.10–1.17) 0.33 0.59
rs10811661 CDKN2B 0.38 0.94 1.13 (0.86–1.49) 0.79 1.21 (1.16–1.26) 0.27 0.63
rs8050136 FTO 0.55 0.15 1.20 (1.02–1.41) 0.45 1.17 (1.12–1.22) 0.45 0.80
ORs and 95% CIs are given per copy of the risk allele, as determined in studies of Caucasians. Results for Pima Indians are derived from the
present study, whereas those from Caucasians represent a combined estimate from other published studies (2–6,18) (see RESEARCH DESIGN AND
METHODS). The heterogeneity power is deﬁned as the power needed to detect signiﬁcant heterogeneity at P  0.05 given the Caucasian OR,
the SE of its logarithm, and the SE of the logarithm of the Pima OR, under the assumption that the “true” OR in the Pima Indians is 1. The
heterogeneity P value is given for the null hypothesis that the ORs in Pima Indians and Caucasians are the same.
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multiple comparisons. For SNPs that are well replicated in
other populations (e.g., rs8050136 in FTO), the prior
probability of a “true positive” is high and, thus, P  0.05
is probably sufﬁcient to conclude that these variants are
also associated in this population. For the additional tag
SNPs, however, this may not be the case, and none of the
nominally signiﬁcant results reported here would remain
signiﬁcant if a Bonferroni correction for the 31 tag SNPs
were applied.
Genotyping of SNPs previously associated with type 2
diabetes in CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2,
CDKN2B, LOC387761, and an intergenic region on chro-
mosome 11p provided no evidence that any of these are
signiﬁcantly associated with type 2 diabetes or obesity
among full-heritage Pima Indians living in the Gila River
Indian Community in Arizona. However, it remains possi-
ble that several of these genes have minor roles in the
development of type 2 diabetes. Both low AIR and de-
creased insulin action (i.e., insulin resistance) are predic-
tors of type 2 diabetes in Pima Indians (34). In the
current study, the Caucasian type 2 diabetes risk alleles
in CDKAL1, HHEX, and EXT2 had nominal associations
with either insulin secretion or insulin action in Pima
Indians with normal glucose tolerance. Although AIR and
insulin action are strongly predictive of type 2 diabetes,
neither trait in itself is completely determinative; there-
fore, it is not surprising that a variant may have a relatively
strong effect on AIR or insulin sensitivity and thus show a
signiﬁcant association, but a relatively weak effect and
thus no signiﬁcant association, on type 2 diabetes. It is also
likely that other genes, with much larger effects on type 2
diabetes, exist in the Pima population and that the effect of
these genes masks any minor role of CDKAL1, HHEX, and
EXT2 in increasing type 2 diabetes risk.
The nominal associations of SNPs in CDKAL1 and
HHEX with two independent measures of insulin secre-
tion (namely, AIR assessed by an IVGTT and 30-min
insulin assessed by an OGTT), where both of these mea-
sures were adjusted for insulin sensitivity, is consistent
with prior association studies. Previous reports that ho-
mozygous carriers of the type 2 diabetes risk allele (G/G)
for rs7756992 in CDKAL1 had a lower corrected insulin
response to an oral glucose load than carriers of the A
allele (3) and that carriers of the type 2 diabetes risk allele
(C) for rs10946398 in CDKAL1 had a reduced 30-min
insulin response (24) suggest a mechanism of impaired
insulin secretion as the basis of the association with type
2 diabetes. Direct evidence that CDKAL1 affects insulin
secretion has recently come from a large study of Euro-
pean Caucasians who had undergone both measures of
insulin secretion using an IVGTT and insulin sensitivity
using a hyperinsulinemic-euglycemic clamp (35). Simi-
larly, previous studies of HHEX in Caucasians have shown
that type 2 diabetes risk allele (C) carriers of rs1111875
had a lower mean insulin response in Caucasians (18,24),
which is also consistent with the known physiological role
of HHEX in pancreatic development. HHEX is highly
expressed in pancreatic islet tissue, and HHEX knockout
mice have a complete loss of ventral pancreas (36).
The strongest replication in this study was the associa-
tion of variation (rs8050136, rs9939609, and rs7193144, all
in complete linkage disequilibrium) in FTO with BMI,
where subjects homozygous for the previously reported
risk allele were on average 1.6 kg/m
2 heavier than homozy-
gotes for the nonrisk allele (heterozygotes were interme-
15
20
25
30
35
40
45 Percent body fat 
P = 0.07
B
o
d
y
 
f
a
t
 
(
%
)
0.40
0.45
0.50
0.55
0.60
0.65
C
Insulin sensitivity  
P = 0.06
d
i
p
o
s
a
l
 
(
m
g
·
k
g
 
E
M
B
S
-
1
·
m
i
n
-
1
)
2.0
2.2
2.4
2.6
2.8
L
o
g
1
0
A
I
R
 
(
µ
U
/
m
l
) Insulin secretion  
P = 0.0001
D
P
r
e
v
a
l
e
n
c
e
 
(
%
)
Type 2 diabetes 
OR=1.10 P = 0.006
0
10
20
30
40
50
60
Number of risk alleles 
<=3 4 5 6 7 8 >=9
Number of risk alleles 
<=3 >=9 45678 <=3 >=9 456 78
Number of risk alleles 
<=3 >=9 45678
FIG. 3. Association of the number of risk alleles in sentinel SNPs with type 2 diabetes (A), percent body fat (B), insulin sensitivity (C), and AIR
(D). Sentinel SNPs are deﬁned as SNPs in CDKAL1 (rs7756992), SLC30A8 (rs13266634), HHEX (rs1111875), IGF2BP2 (rs4402960), CDKN2B
(rs10811661), FTO (rs8050136), and TCF7L2 (rs7903146). Risk alleles are deﬁned from studies in Caucasians (see Table 1). Numbers of
individuals in each of the allelic groups (<3, 4, 5, 6, 7, 8, and >9) are 55, 295, 668, 795, 524, 329, and 77, respectively, for type 2 diabetes; 9, 43,
82, 85, 49, 21, and 11 for percent body fat and insulin sensitivity; and 5, 32, 60, 59, 35, 14, and 8 for insulin secretion.
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Indians. In addition, among the subset of subjects who had
undergone subcutaneous adipose biopsies, subjects ho-
mozygous for the risk allele had larger individual adipo-
cytes, even after adjusting for their higher percentage of
body fat. FTO encodes a 2-oxoglutarate–dependent nu-
cleic acid demethylase, which is highly expressed in
hypothalamic nuclei and is thought to be regulated by
fasting and feeding conditions (37). FTO is also expressed
in adipose tissue, but FTO mRNA is not correlated with
rs9939609 or rs8050136 (38,39). Healthy women homozy-
gous for the obesity-protective FTO allele have an 30%
increased in vivo lipolytic activity (assessed as circulating
glycerol corrected for total body fat), which is likely due to
their increased spontaneous (basal) fat cell lipolysis (39).
This ﬁnding is consistent with our observation of a differ-
ence in fat cell size by FTO genotype, where homozygotes
for the protective genotype had signiﬁcantly less lipid per
cell (Table 3).
Most of the variants identiﬁed in previous GWA studies
have fairly modest effects in Caucasian populations with
ORs in the range of 1.1–1.2. Even with the present sample
size of 3,500 Pima subjects, there is only moderate
power to detect (or exclude) associations of this magni-
tude. If most of these variants do have modest effects in
Pima Indians, one would expect power to be increased in
a multiallelic analysis that considers the total number of
risk alleles across all variants. The present analyses did
show a nominally signiﬁcant, albeit modest, association of
the number of risk alleles with type 2 diabetes. Further-
more, there was a marked association between number of
risk alleles at these loci and a diminished AIR but not with
other quantitative metabolic risk factors for type 2 diabe-
tes, such as percent body fat or insulin sensitivity. These
data are consistent with the hypothesis that many of the
diabetes risk variants in Caucasians also have subtle
effects in Pima Indians, although the statistical power of
the present study is not sufﬁcient to identify individual risk
variants with conﬁdence. In addition, the multiallelic anal-
ysis is consistent with the hypothesis that most of these
variants inﬂuence the risk of type 2 diabetes through their
effect on insulin secretion.
We have previously reported that variation in TCF7L2,
which has shown the strongest association with type 2
diabetes across many populations, has minimal, if any,
impact on this disease in Pima Indians (8). The variants
presented in this paper, which also have well-replicated
associations with both type 2 diabetes and measures of
insulin secretion among Caucasians, do not have a major
effect on type 2 diabetes in Pima Indians, although an
association with AIR was observed. It is possible that
these ﬁndings may be explained by a relatively smaller
contribution of insulin secretory dysfunction to the occur-
rence of diabetes in Pima Indians compared with Cauca-
sians, but insufﬁcient data are available at present to
evaluate this hypothesis. To determine whether additional
variants exist with stronger effects in Pima Indians or
other populations at high risk for diabetes among whom
the relative contributions of obesity, insulin resistance,
and insulin secretory dysfunction may differ will require
mapping studies speciﬁc for these populations. In the
present study, genotyping of additional tag SNPs in
CDKAL1, SLC30A8, and IGF2BP2 did not reveal alter-
native variants associated with type 2 diabetes in Pima
Indians; however, important variation could have been
missed because these genes were interrogated by tag
SNPs with a criteria of r
2  0.5 rather than the more
customary r
2  0.8.
In summary, when examined individually, variants in
CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, CDKN2B,
and LOC387761 associated with type 2 diabetes in other
populations were not signiﬁcantly associated with type 2
diabetes in Pima Indians. However, taken together, they
had a modest additive association with type 2 diabetes and
a strong association with decreased insulin secretion. In
addition, previously reported variation in FTO does have a
role in determining BMI and type 2 diabetes in the Pima
Indian population. A recent report by the Diabetes Genet-
ics Replication and Meta-Analysis consortium has de-
scribed six additional type 2 diabetes susceptibility loci
identiﬁed via GWA methods (40). Studies of these loci in
Pima Indians are ongoing.
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